Abstract:The development of CRISPR-based gene-editing technologies has brought an unprecedented revolution in the field of genome engineering. Cas12a, a member of the Class 2 Type V CRISPR-associated endonuclease family distinct from Cas9, has been repurposed and developed into versatile gene-editing tools with distinct PAM recognition sites and multiplexed gene targeting capability. However, with current CRISPR/Cas12a technologies, it remains a challenge to perform efficient and precise genome editing of long sequences in mammalian cells. To address this limitation, we utilized phage recombination enzymes and developed an efficient CRISPR/Cas12a tool for multiplexed precision editing in mammalian cells. Through protein engineering, we were able to recruit phage recombination proteins to Cas12a to enhance its homology-directed repair efficiencies. Our phage-recombination-assisted Cas12a system achieved up to 3-fold improvements for kilobase-scale knock-ins in human cells without compromising the specificity of the enzyme. The performance of this system compares favorably against Cas9 references, the commonly used enzyme for gene-editing tasks, with improved specificity. Additionally, we demonstrated multi-target editing with similar improved activities thanks to the RNA-processing activity of the Cas12a system. This compact, multi-target editing tool has the potential to assist in understanding multi-gene interactions. In particular, it paves the way for a gene therapy method for human diseases that complements existing tools and is suitable for polygenic disorders and diseases requiring long-sequence corrections.

Engineering transposon-associated TnpB-ωRNA system for efficient gene editing and disease treatment in mouse

Engineering a Transposon-Associated TnpB-ωRNA System for Efficient Gene Editing and Phenotypic Correction of a Tyrosinaemia Mouse Model

Effective genome editing with an enhanced ISDra2 TnpB system and deep learning-predicted ωRNAs

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Engineering CRISPR/Cpf1 with tRNA promotes genome editing capability in mammalian systems

Engineered IscB-ωRNA system with improved base editing efficiency for disease correction via single AAV delivery in mice

Evolutionary mining and functional characterization of TnpB nucleases identify efficient miniature genome editors

Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing

Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system

Genome editing in plants using the TnpB transposase system

Engineered IscB-ωRNA system with expanded target range for base editing

Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryos

Flexible TAM requirement of TnpB enables efficient single-nucleotide editing with expanded targeting scope

Design and application of the transformer base editor in mammalian cells and mice

Discovery and structural mechanism of DNA endonucleases guided by RAGATH-18-derived RNAs

Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Non-viral Delivery of Zinc Finger Nuclease mRNA Enables Highly Efficient In Vivo Genome Editing of Multiple Therapeutic Gene Targets

Versatile and Efficient Genome Editing with Neisseria Cinerea Cas9

Transcription-coupled Donor DNA Expression Increases Homologous Recombination for Efficient Genome Editing

A non-inheritable maternal Cas9-based multiple-gene editing system in mice